Document:

Promissory Note

 Exhibit 10.77 
 PROMISSORY NOTE 
  
 THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAW OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 
  

			
	 $100,000.00
	 	September 1, 2001

  
 Englewood Cliffs, NJ

  
 FOR VALUE RECEIVED, the receipt of which is hereby
acknowledged, BIOVEST INTERNATIONAL, INC., a Delaware corporation having its corporate office at 540 Sylvan Avenue, Englewood Cliffs, New Jersey 07632 (the “Company”), hereby promises to pay to the order of Ioannis Kordistos, having an
address of 1455 Cropsey Avenue, Brooklyn NY 11228 (“Holder”), or such other address as Holder may notify the Company, the principal sum of $100,000.00 (the “Principal”), together with interest thereon, as follows: 
  

	1.	 	Accrual of Interest. Interest shall accrue on the outstanding balance of Principal from time to time at the rate of 10% per annum. No payment of interest shall be due until
maturity. 

  

	2.	 	Maturity. The Principal amount due under this Note shall become immediately due and payable to Holder automatically and without further action or notice on the part of
Holder, upon the one year anniversary of the date of this Note 

  

	3.	 	Prepayment. All payments due under this Note shall be made by check payable to HOLDER. The Company, at its option, may prepay this Note at any time in whole or in part
without premium or penalty, subject to HOLDER’s right to convert the sums due hereunder to equity as set forth in paragraph (4) herein. 

  

	4.	 	Option to Convert To Equity. At any time prior to the six month anniversary date, or prior to payment of the outstanding sums due under this Note, HOLDER may elect to convert
the outstanding balance due to equity ownership of Common Stock of the Company at the rate of $3.00 per share of common stock. This exercise shall be made in writing, addressed to the Company at its Executive Offices at 540 Sylvan Avenue, Englewood
Cliffs, NJ 07632. 

  

	5.	 	 Miscellaneous. Notwithstanding any provision herein or in any documents or instrument now or hereafter securing this Note, the total liability for payments
in the nature of interest shall not exceed the limits now or at any time in the future imposed by the applicable laws of the State of New York. This Note shall be governed by, and construed 

 
in accordance with, the laws of the State of New York applicable to agreements entered into and to be performed entirely within such State. 
  
 IN WITNESS WHEREOF, this Note has been executed as of the date first above
written. 
  

			
	BIOVEST INTERNATIONAL, INC.
		
	 By:
	 	 /s/    Othon Mourkakos

		
	 Name:
	 	 Othon Mourkakos

		
	 Title:
	 	 President

  

 2 

 January 18, 2005 
  
 Modification of Promissory Note Dated September 1, 2001 
  
 BioVest International, Inc. and Ioannis Kordistos hereby agree as follows: 
  
 This letter-agreement sets forth the terms of a modification and extension of the Promissory Note dated September 1, 2001 (the “Promissory Note”) from BioVest
(previously Cellex Biosciences, Inc.) payable to Mr. Kordistos. In settlement of any and all outstanding claims or obligations arising from this Promissory Note, and by way of modification of the payment schedule contained therein, BioVest and
Ioannis Kordistos hereby agree to the following: 
  

	 	1.	 	The sum owed by BioVest under the Promissory Note, including interest, is $127,835.62 (the “Agreed Note Amount”) as of December 15, 2004. BioVest will pay the Agreed Note
Amount, with continuing interest at the rate of 10% per annum, in twelve equal monthly installments of $11,238.73 per month commencing on January 21, 2005 and on the fifteenth day of each month thereafter until the final payment of $ 11,238.73 due
and payable on December 15, 2005. 

  

	 	2.	 	BioVest will deliver a form of Confession of Judgment in the full amount owed as set forth in paragraph 1 above, to be held in escrow by Nicholas J. Sekas, Esq. The terms of the
Confession of Judgment shall provide that upon a default in the scheduled payments by BioVest, after 20 days written notice delivered to James McNulty, CPA, 5310 Cypress Center Drive # 101, Tampa, FL 33609, which default remains uncured after such
20-day period, the Judgment may be entered for the balance due, after deduction of any payments previously made pursuant to this modification agreement. 

  

	 	3.	 	All shares of common stock owned by Mr. Kordistos, and any Options or Warrants to purchase shares of BioVest which have been granted to him will remain outstanding under their
terms. 

  

	 	4.	 	The terms set forth above shall constitute an extension and modification of the payment schedule and the terms of the Promissory Note. So long as BioVest makes the payments as
required herein, the Promissory Note will be considered in good standing and current pursuant to these modified terms. 

  

 3 

 Once signed below by you and by BioVest, this letter-agreement will constitute an agreement binding on
both BioVest and you. 
  
 The undersigned for good and valuable consideration
acknowledge and agree to the terms of settlement and modification of the Promissory Note set forth hereinabove. 
  

			
	 BioVest International, Inc.
  
 By  
/s/    David Moser                    

       David Moser, Director of Legal Affairs
	  	  
  
 Date:                 

  

			
	  
 /s/    Ioannis Kordistos                    

 Mr. Ioannis Kordistos
	  	  
 Date:
                

  
  

 4Promissory Note, dated Sept 1, 2001, of Registrant payable to Dr Robert Evans

 PROMISSORY NOTE 
  
 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAW OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 
  

				
	$	100,000.00	 	May 2, 2002

  
 Englewood Cliffs, NJ

  
 FOR VALUE RECEIVED, the receipt of which is hereby
acknowledged, BIOVEST INTERNATIONAL, INC., a Delaware corporation having its corporate office at 540 Sylvan Avenue, Englewood Cliffs, New Jersey 07632 (the “Company”), hereby promises to pay to the order of Dr. Robert Evans having an
address of 111 Serpentine Drive, Tenafly N.J. 07670 (“Holder”), or such other address as Holder may notify the Company, the principal sum of $100,000.00 (the “Principal”), together with interest thereon, as follows: 

 

	1.	 	Accrual of Interest. Interest shall accrue on the outstanding balance of Principal from time to time at the rate of 7.5% per annum. No payment of interest shall be due until
maturity. 

  

	2.	 	Maturity. The Principal amount due under this Note shall become immediately due and payable to Holder automatically and without further action or notice on the part of
Holder, on November 2, 2002 (the “Maturity Date”). 

  

	3.	 	Prepayment. All payments due under this Note shall be made by check payable to HOLDER. The Company, at its option, may prepay this Note at any time in whole or in part
without premium or penalty, subject to HOLDER’s right to convert the sums due hereunder to equity as set forth in paragraph (4) herein. 

  

	4.	 	Option to Convert To Equity. At any time prior to the maturity date, or prior to payment of the outstanding sums due under this Note, HOLDER may elect to convert the
outstanding balance due, including accrued interest, to equity ownership of Common Stock of the Company at the rate of $3.00 per share of common stock. This exercise shall be made in writing, addressed to the Company at its Executive Offices at 540
Sylvan Avenue, Englewood Cliffs, NJ 07632. 

  

	5.	 	Miscellaneous. Notwithstanding any provision herein or in any documents or instrument now or hereafter securing this Note, the total liability for payments in the nature of
interest shall not exceed the limits now or at any time in the future imposed by the applicable laws of the State of New York. This Note shall be governed by, and construed 

 
in accordance with, the laws of the State of New York applicable to agreements entered into and to be performed entirely within such State. 
  
 IN WITNESS WHEREOF, this Note has been executed as of the date first above written.

  

			
	BIOVEST INTERNATIONAL, INC.
		
	 By:
	 	 /s/    Othon Mourkakos

		
	 Name:
	 	 Othon Mourkakos

		
	 Title:
	 	 President

  

 2 

 February 28, 2005 
  
 Dr. Robert Evans 
 111 Serpentine Drive 
 Tenafly NJ 07670 
  
 Modification of Promissory Note Dated November 2, 2001 
  
 BioVest International, Inc. and Dr. Robert Evans hereby agree as follows: 
  
 This letter-agreement sets forth the terms of a modification and extension of the Promissory Note dated November 2,, 2001 (the “Promissory Note”) from BioVest (previously Cellex Biosciences, Inc.) payable to Dr. Evans. In
settlement of any and all outstanding claims or obligations arising from this Promissory Note, and by way of modification of the payment schedule contained therein, BioVest and Dr. Robert Evans hereby agree to the following: 
  

	 	1.	 	The sum owed by BioVest under the Promissory Note, including interest, is $125,376.71 (the “Agreed Note Amount”) as of February 28, 2005. BioVest will pay the Agreed Note
Amount, with continuing interest at the rate of 7.5 % per annum, in twelve equal monthly installments of $10,877.36 per month commencing on March 15, 2005 and on the fifteenth day of each month thereafter until the final payment of $ 10,877.36 due
and payable on February 15, 2006. 

  

	 	2.	 	BioVest will deliver a form of Confession of Judgment in the full amount owed as set forth in paragraph 1 above. The terms of the Confession of Judgment shall provide that upon a
default in the scheduled payments by BioVest, after 20 days written notice delivered to James McNulty, CPA, 5310 Cypress Center Drive # 101, Tampa, FL 33609, which default remains uncured after such 20-day period, the Judgment may be entered for the
balance due, after deduction of any payments previously made pursuant to this modification agreement. 

  

	 	3.	 	All shares of common stock owned by Dr. Evans, and any Options or Warrants to purchase shares of BioVest which have been granted to him will remain outstanding under their terms.

  

	 	4.	 	The terms set forth above shall constitute an extension and modification of the payment schedule and the terms of the Promissory Note. So long as BioVest makes the payments as
required herein, the Promissory Note will be considered in good standing and current pursuant to these modified terms. 

  
  

 3 

 Once signed below by you and by BioVest, this letter-agreement will constitute an agreement binding on
both BioVest and you. 
  
 The undersigned for good and valuable consideration
acknowledge and agree to the terms of extension and modification of the Promissory Note set forth hereinabove. 
  
 BioVest International, Inc. 
  

					
			
	 By  
	 	/s/ David Moser	 	Date:                      
	 	 	David Moser, Director of Legal Affairs	 	 
			
	 	 	/s/ Dr. Robert Evans	 	Date:                      
	 	 	Dr. Robert Evans	 	 

  
  
  
  
  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]